Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

97 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Inflammatory-Related Genetic Variants in Non-Muscle-Invasive Bladder Cancer Prognosis: A Multimarker Bayesian Assessment.
Masson-Lecomte A, López de Maturana E, Goddard ME, Picornell A, Rava M, González-Neira A, Márquez M, Carrato A, Tardon A, Lloreta J, Garcia-Closas M, Silverman D, Rothman N, Kogevinas M, Allory Y, Chanock SJ, Real FX, Malats N; SBC/EPICURO Study Investigators. Masson-Lecomte A, et al. Among authors: rava m. Cancer Epidemiol Biomarkers Prev. 2016 Jul;25(7):1144-50. doi: 10.1158/1055-9965.EPI-15-0894. Epub 2016 May 6. Cancer Epidemiol Biomarkers Prev. 2016. PMID: 27197286 Free PMC article.
Asthma status is associated with decreased risk of aggressive urothelial bladder cancer.
Rava M, Czachorowski MJ, Silverman D, Márquez M, Kishore S, Tardón A, Serra C, García-Closas M, Garcia-Closas R, Carrato A, Rothman N, Real FX, Kogevinas M, Malats N. Rava M, et al. Int J Cancer. 2018 Feb 1;142(3):470-476. doi: 10.1002/ijc.31066. Epub 2017 Oct 16. Int J Cancer. 2018. PMID: 28940228 Free PMC article.
Bladder Cancer Genetic Susceptibility. A Systematic Review.
de Maturana EL, Rava M, Anumudu C, Sáez O, Alonso D, Malats N. de Maturana EL, et al. Among authors: rava m. Bladder Cancer. 2018 Apr 26;4(2):215-226. doi: 10.3233/BLC-170159. Bladder Cancer. 2018. PMID: 29732392 Free PMC article.
Diagnostic and Prognostic Performance of Secreted Protein Acidic and Rich in Cysteine (SPARC) Assay for Detecting Primary and Recurrent Urinary Bladder Cancer.
Critselis E, Rava M, Marquez M, Lygirou V, Chatzicharalambous D, Liapi P, Lichtinghagen R, Brand K, Cecchini L, Vlahou A, Malats N, Zoidakis J. Critselis E, et al. Among authors: rava m. Proteomics Clin Appl. 2019 Mar;13(2):e1800148. doi: 10.1002/prca.201800148. Epub 2019 Jan 30. Proteomics Clin Appl. 2019. PMID: 30632279
Immunohistochemistry-Based Taxonomical Classification of Bladder Cancer Predicts Response to Neoadjuvant Chemotherapy.
Font A, Domènech M, Benítez R, Rava M, Marqués M, Ramírez JL, Pineda S, Domínguez-Rodríguez S, Gago JL, Badal J, Carrato C, López H, Quer A, Castellano D, Malats N, Real FX. Font A, et al. Among authors: rava m. Cancers (Basel). 2020 Jul 3;12(7):1784. doi: 10.3390/cancers12071784. Cancers (Basel). 2020. PMID: 32635360 Free PMC article.
CD8+ Cytotoxic Immune Infiltrate in Non-Muscle Invasive Bladder Cancer: A Standardized Methodology to Study Association with Clinico-Pathological Features and Prognosis.
Masson-Lecomte A, Maillé P, Pineda S, Soyeux P, Sagrera A, Rava M, de Maturana EL, Márquez M, Tardón A, Carrato A, Kogevinas M, de la Taille A, Hartmann A, Malats N, Real P, Allory Y. Masson-Lecomte A, et al. Among authors: rava m. Bladder Cancer. 2019;5(2):159-169. doi: 10.3233/blc-180206. Epub 2019 Aug 16. Bladder Cancer. 2019. PMID: 36157135 Free PMC article.
A systems approach identifies time-dependent associations of multimorbidities with pancreatic cancer risk.
Gomez-Rubio P, Rosato V, Márquez M, Bosetti C, Molina-Montes E, Rava M, Piñero J, Michalski CW, Farré A, Molero X, Löhr M, Ilzarbe L, Perea J, Greenhalf W, O'Rorke M, Tardón A, Gress T, Barberá VM, Crnogorac-Jurcevic T, Muñoz-Bellvís L, Domínguez-Muñoz E, Gutiérrez-Sacristán A, Balsells J, Costello E, Guillén-Ponce C, Huang J, Iglesias M, Kleeff J, Kong B, Mora J, Murray L, O'Driscoll D, Peláez P, Poves I, Lawlor RT, Carrato A, Hidalgo M, Scarpa A, Sharp L, Furlong LI, Real FX, La Vecchia C, Malats N; PanGenEU Study Investigators. Gomez-Rubio P, et al. Among authors: rava m. Ann Oncol. 2017 Jul 1;28(7):1618-1624. doi: 10.1093/annonc/mdx167. Ann Oncol. 2017. PMID: 28383714 Free article.
Reduced risk of pancreatic cancer associated with asthma and nasal allergies.
Gomez-Rubio P, Zock JP, Rava M, Marquez M, Sharp L, Hidalgo M, Carrato A, Ilzarbe L, Michalski C, Molero X, Farré A, Perea J, Greenhalf W, O'Rorke M, Tardón A, Gress T, Barberà V, Crnogorac-Jurcevic T, Domínguez-Muñoz E, Muñoz-Bellvís L, Alvarez-Urturi C, Balcells J, Barneo L, Costello E, Guillén-Ponce C, Kleeff J, Kong B, Lawlor R, Löhr M, Mora J, Murray L, O'Driscoll D, Peláez P, Poves I, Scarpa A, Real FX, Malats N; PanGenEU Study Investigators. Gomez-Rubio P, et al. Among authors: rava m. Gut. 2017 Feb;66(2):314-322. doi: 10.1136/gutjnl-2015-310442. Epub 2015 Dec 1. Gut. 2017. PMID: 26628509 Review.
Development and Validation of Urine-based Peptide Biomarker Panels for Detecting Bladder Cancer in a Multi-center Study.
Frantzi M, van Kessel KE, Zwarthoff EC, Marquez M, Rava M, Malats N, Merseburger AS, Katafigiotis I, Stravodimos K, Mullen W, Zoidakis J, Makridakis M, Pejchinovski M, Critselis E, Lichtinghagen R, Brand K, Dakna M, Roubelakis MG, Theodorescu D, Vlahou A, Mischak H, Anagnou NP. Frantzi M, et al. Among authors: rava m. Clin Cancer Res. 2016 Aug 15;22(16):4077-86. doi: 10.1158/1078-0432.CCR-15-2715. Epub 2016 Mar 29. Clin Cancer Res. 2016. PMID: 27026199
97 results